
Lilly acquires biotech startup founded by WashU Med researchers
Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.
Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.
More great ink for Washington University in St Louis inventors Jen and Jon Silva.
The new test is faster and simpler than nasal and oral swab tests and enables screening on a massive scale.
In the video, they demonstrate their breakthrough AR technology that visualizes a patient’s heart in 3D during surgery.
Two members of the Washington University in St. Louis community have been named National Academy of Inventors fellows.
A St. Louis-based startup cofounded by a Washington University physician has raised a combined $6.6 million in federal grant funding and private investment, reports the St. Louis Business Journal.
Erica Barnell, an MD/PhD candidate at Washington University School of Medicine in St. Louis, has been named to Forbes 30 Under 30 in the Healthcare category.
Centene will fund up to $100M over 10 years in research at Washington University School of Medicine.
Two faculty members at Washington University School of Medicine in St. Louis have been named senior members of the National Academy of Inventors (NAI).